All Posts: immunotherapy
-
Study Shows Why a Common Form of Immunotherapy Fails, and Suggests Solution
Category: News Release
-
Patient Groups Untested in Cancer Immunotherapy Trials Found to Also Benefit
Category: News Release
-
Study Finds HIV+ Cancer Patients Benefit From Immunotherapy
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (February 7, 2019) — The immunotherapy that has revolutionized treatment of many cancers appears to offer similar benefit to cancer patients living with HIV, say researchers at Georgetown Lombardi Comprehensive Cancer Center. Their study, published in JAMA Oncology, focused on whether a relatively new class of drugs called checkpoint inhibitors is both safe and […]
Category: News Release
-
Precision Medicine and Immunotherapy: Tomorrow's Cancer Treatments Today at Georgetown Lombardi
Diane Lucey’s unusual cancer stumped her doctors. But after ordering a profile of her tumor, medical oncologist Louis Weiner knew exactly how to proceed.
Category: GUMC Stories
-
Georgetown Seeks Volunteers for New Immunotherapy Clinical Trial for Alzheimer’s
WASHINGTON — The Memory Disorders Program at Georgetown University is seeking volunteers to participate in an international clinical trial of a drug that, in an early phase study, has demonstrated promise in slowing mental decline in Alzheimer’s disease. Georgetown is the only institution in the greater Washington, DC, area offering access to the phase 3 study of the investigational immunotherapy drug aducanumab.
Category: News Release
-
As Medicine Gets More Precise, Complexities Mount
Doctors Speak Out (December 06, 2013) — Once regarded as the “medicine of science fiction,” the idea of being able to personalize health care based on a person’s individual characteristics is now
Category: GUMC Stories